Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02134015
Brief Title: Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung) (HER3-Lung)

First Submitted : April 8, 2014
First Submitted that Met QC Criteria : May 6, 2014
First Posted : May 8, 2014 (Estimate)

Results First Submitted : November 29, 2017
Results First Submitted that Met QC Criteria : December 22, 2017
Results First Posted : January 23, 2018

Last Update Submitted that Met QC Criteria : December 22, 2017
Last Update Posted : January 23, 2018